[1] 郝娜, 杨宏军, 王长法等. 奶牛乳腺炎金黄色葡萄球菌疫苗研究进展[J]. 动物医学进展. 2009, 1: 93-99. [2] 邓军昌. 浅谈鸡葡萄球菌病的诊断与防治[J]. 中国畜牧兽医文摘. 2012, 10: 190-191. [3] 罗祥文,汤小燕. 金黄色葡萄球菌的临床分布及耐药性分析[J]. 2012, 17(3): 422-424. [4] Daniel A, Euler C, Collin M, et al. Synergism between a novel chimeric lysin and oxacillin protects against infection by methicillin resistant Staphylococcus aureus [J]. Antimicrob Agents Chemother. 2010, 54(4): 1603-1612. [5] Glowalla E, Tosetti B, Kr?nke M, et al. Proteomics-based identification of anchorless cell wall proteins as vaccine candidates against Staphylococcus aureus [J]. Infect Immun. 2009, 77(7):2719-2729. [6] Ragle BE, Bubeck Wardenburg J. Anti-alpha-hemolysin monoclonal antibodies mediate protection against Staphylococcus aureus pneumonia [J]. Infect Immun. 2009, 77(7): 2712-2718. [7] 陈益国, 阳大庆, 富宁. 金葡菌疫苗的研究进展[J]. 中国生物制品学杂志. 2010, 23(11): 1271-1274 [8] Sorensen A L, Nagai S, Houen G, et al. Purification and characterization of a low-molecular-mass T-cell antigen secreted by Mycobacterium tuberculosis [J]. Infect Immun. 1995, 63(5): 1710-1717. [9] Burts M L, Williams W A, DeBord K, et al. EsxA and EsxB are secreted by an ESAT-6-like system that is required for the pathogenesis of Staphylococcus aureus infections [J]. Proc Natl Acad Sci USA. 2005, 102(4): 1169-1174. [10] Bagnoli F, Fontana M R, Soldaini E, et al. Vaccine composition formulated with a novel TLR7-dependent adjuvant induces high and broad protection against Staphylococcus aureus [J]. Proc Natl Acad Sci USA. 2015, 112(12): 3680-3685. [11] 焦新安, 杨静, 王志亮等. 沙门氏菌属鞭毛蛋白共同抗原表位的初步定位[J]. 中华微生物与免疫学杂志. 1993, 13(6): 351-353. [12] 程禹, 罗敏玉, 陈代杰. 耐甲氧西林金葡菌到万古霉素高度耐药金葡菌的发展及其感染的药物治疗[J]. 世界临床药物. 2011, 32(08): 482-487. [13] Fuda C, Suvorov M, Vakulenko S B, et al. The basis for resistance to β-lactam antibiotics by penicillin-binding protein 2a of methicillin-resistant Staphylococcus aureus [J]. J Biol Chem. 2004, 279(39): 40802-40806. [14] 杨益隆. 金黄色葡萄球菌疫苗及其免疫治疗进展[J]. 微生物免疫学进展. 2012, 40(2): 47-52. [15] García-Lara J, Foster SJ. Anti-Staphylococcus aureus immunotherapy: current status and prospects [J]. Curr. Opin. Pharmacol. 2009, 9(5), 552–557. [16] García V, Gómez M, Iglesias M, et al. Intramammary immunization with live-attenuated Staphylococcus aureus: microbiological and immunological studies in a mouse mastitis model. FEMS Immunol Med Microbiol. 1996, 14(1):45-51. [17] Lee JW, O'Brien CN, Guidry AJ, et al. Effect of a trivalent vaccine against Staphylococcus aureus mastitis lymphocyte subpopulations, antibody production, and neutrophil phagocytosis [J]. Can J Vet Res. 2005, 69(1): 11-8. [18] Bubeck Wardenburg J, Schneewind O. Vaccine protection against Staphylococcus aureus pneumonia [J]. J Exp Med. 2008, 205(2): 287-94. [19] Burts ML, DeDent AC, Missiakas DM. EsaC substrate for the ESAT-6 secretion pathway and its role in persistent infections of Staphylococcus aureus. Mol Microbiol [J]. 2008, 69(3):736-46. [20] Andersen MH, Schrama D, Thor Straten P, et al. Cytotoxic T cells [J]. J Invest Dermatol. 2006 , 126(1): 32-41.
|